Skip to main content

Advertisement

SpringerLink
Log in

Association between CCND1 and XPC polymorphisms and bladder cancer risk: a meta-analysis based on 15 case–control studies

  • Research Article
  • Published:
Tumor Biology

Abstract

Perturbations in cell cycle and DNA repair genes might affect susceptibility to cancer. The aim of this meta-analysis is to generate large-scale evidence to determine the degree to which common Cyclin D1 (CCND1) G870A (dbSNP: rs603965) and xeroderma pigmentosum group C (XPC) Ala499Val (dbSNP: rs2228000) polymorphisms are associated with susceptibility to bladder cancer. The electronic databases PubMed, Embase, Web of Science, and CNKI were searched for relevant studies (with an upper date limit of July 25, 2013). The principal outcome measure for evaluating the strength of association was crude odds ratios (ORs) along with their corresponding confidence intervals (95 %CIs). We found and reviewed nine case–control studies on CCND1 G870A with a total of 6,823 subjects and seven studies on XPC Ala499Val with a total of 7,674 subjects. Our meta-analysis provides evidence that the variant genotype of CCND1 G870A showed a significant association in the occurrence of invasive bladder tumors in former and current smokers. The XPC Ala499Val polymorphism correlated with significant differences between patients and unaffected subjects, but when the groups were stratified by ethnicity, the magnitude of the overall effect was similar only among Caucasian populations. Results from our meta-analysis support the view that the G870A polymorphism may modulate the risk of bladder cancer in conjunction with tobacco smoking and that the Ala499Val polymorphism may contribute to the susceptibility to bladder cancer in Caucasian populations. Our findings, however, warrant larger well-designed studies to investigate the significance of these two polymorphisms as markers of susceptibility to bladder cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.

    Article  PubMed  Google Scholar 

  2. Actinomycin C. Cumulative index to IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans. IARC Monogr Eval Carcinog Risk Chem Hum. 1986;39:379–403.

    Google Scholar 

  3. Murta-Nascimento C, Schmitz-Drager BJ, Zeegers MP, Steineck G, Kogevinas M, et al. Epidemiology of urinary bladder cancer: from tumor development to patient's death. World J Urol. 2007;25:285–95.

    Article  PubMed  Google Scholar 

  4. Vineis P, Talaska G, Malaveille C, Bartsch H, Martone T, et al. DNA adducts in urothelial cells: relationship with biomarkers of exposure to arylamines and polycyclic aromatic hydrocarbons from tobacco smoke. Int J Cancer. 1996;65:314–6.

    Article  CAS  PubMed  Google Scholar 

  5. Turesky RJ, Freeman JP, Holland RD, Nestorick DM, Miller DW, et al. Identification of aminobiphenyl derivatives in commercial hair dyes. Chem Res Toxicol. 2003;16:1162–73.

    Article  CAS  PubMed  Google Scholar 

  6. Burger MS, Torino JL, Swaminathan S. DNA damage in human transitional cell carcinoma cells after exposure to the proximate metabolite of the bladder carcinogen 4-aminobiphenyl. Environ Mol Mutagen. 2001;38:1–11.

    Article  CAS  PubMed  Google Scholar 

  7. Siraki AG, Chan TS, Galati G, Teng S, O'Brien PJ. N-oxidation of aromatic amines by intracellular oxidases. Drug Metab Rev. 2002;34:549–64.

    Article  CAS  PubMed  Google Scholar 

  8. Wei Q, Spitz MR. The role of DNA repair capacity in susceptibility to lung cancer: a review. Cancer Metastasis Rev. 1997;16:295–307.

    Article  CAS  PubMed  Google Scholar 

  9. Kaufmann WK, Paules RS. DNA damage and cell cycle checkpoints. FASEB J. 1996;10:238–47.

    CAS  PubMed  Google Scholar 

  10. Ronen A, Glickman BW. Human DNA repair genes. Environ Mol Mutagen. 2001;37:241–83.

    Article  CAS  PubMed  Google Scholar 

  11. Wood RD, Mitchell M, Sgouros J, Lindahl T. Human DNA repair genes. Science. 2001;291:1284–9.

    Article  CAS  PubMed  Google Scholar 

  12. Friedberg EC. How nucleotide excision repair protects against cancer. Nat Rev Cancer. 2001;1:22–33.

    Article  CAS  PubMed  Google Scholar 

  13. Tauchi H, Kobayashi J, Morishima K, van Gent DC, Shiraishi T, et al. Nbs1 is essential for DNA repair by homologous recombination in higher vertebrate cells. Nature. 2002;420:93–8.

    Article  CAS  PubMed  Google Scholar 

  14. Matullo G, Guarrera S, Carturan S, Peluso M, Malaveille C, et al. DNA repair gene polymorphisms, bulky DNA adducts in white blood cells and bladder cancer in a case–control study. Int J Cancer. 2001;92:562–7.

    Article  CAS  PubMed  Google Scholar 

  15. Wang M, Gu D, Zhang Z, Zhou J. XPD polymorphisms, cigarette smoking, and bladder cancer risk: a meta-analysis. J Toxicol Environ Health A. 2009;72:698–705.

    Article  CAS  PubMed  Google Scholar 

  16. Li C, Jiang Z, Liu X. XPD Lys(751)Gln and Asp (312)Asn polymorphisms and bladder cancer risk: a meta-analysis. Mol Biol Rep. 2010;37:301–9.

    Article  CAS  PubMed  Google Scholar 

  17. Sun H, Qiao Y, Zhang X, Xu L, Jia X, et al. XRCC3 Thr241Met polymorphism with lung cancer and bladder cancer: a meta-analysis. Cancer Sci. 2010;101:1777–82.

    Article  CAS  PubMed  Google Scholar 

  18. Li F, Li C, Jiang Z, Ma N, Gao X. XRCC3 T241M polymorphism and bladder cancer risk: a meta-analysis. Urology. 2011;77(511):e1–5.

    Google Scholar 

  19. Zhang Y, Wang X, Zhang W, Gong S. An association between XPC Lys939Gln polymorphism and the risk of bladder cancer: a meta-analysis. Tumour Biol. 2013;34:973–82.

    Article  CAS  PubMed  Google Scholar 

  20. Dou K, Xu Q, Han X. The association between XPC Lys939Gln gene polymorphism and urinary bladder cancer susceptibility: a systematic review and meta-analysis. Diagn Pathol. 2013;8:112.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  21. Liu C, Yin Q, Li L, Zhuang YZ, Zu X, et al. APE1 Asp148Glu gene polymorphism and bladder cancer risk: a meta-analysis. Mol Biol Rep. 2013;40:171–6.

    Article  PubMed  Google Scholar 

  22. Zhang F, Wu JH, Zhao W, Liu HT. XRCC1 polymorphisms increase bladder cancer risk in Asians: a meta-analysis. Tumour Biol. 2013

  23. Wang C, Sun Y, Han R. XRCC1 genetic polymorphisms and bladder cancer susceptibility: a meta-analysis. Urology. 2008;72:869–72.

    Article  PubMed  Google Scholar 

  24. Lao T, Gu W, Huang Q. A meta-analysis on XRCC1 R399Q and R194W polymorphisms, smoking and bladder cancer risk. Mutagenesis. 2008;23:523–32.

    Article  CAS  PubMed  Google Scholar 

  25. Lee CC, Yamamoto S, Morimura K, Wanibuchi H, Nishisaka N, et al. Significance of cyclin D1 overexpression in transitional cell carcinomas of the urinary bladder and its correlation with histopathologic features. Cancer. 1997;79:780–9.

    Article  CAS  PubMed  Google Scholar 

  26. Hosokawa Y, Arnold A. Mechanism of cyclin d1 (CCND1, PRAD1) overexpression in human cancer cells: analysis of allele-specific expression. Genes Chromosomes Cancer. 1998;22:66–71.

    Article  CAS  PubMed  Google Scholar 

  27. Zhou P, Jiang W, Weghorst CM, Weinstein IB. Overexpression of cyclin D1 enhances gene amplification. Cancer Res. 1996;56:36–9.

    CAS  PubMed  Google Scholar 

  28. Sugasawa K, Shimizu Y, Iwai S, Hanaoka F. A molecular mechanism for DNA damage recognition by the xeroderma pigmentosum group C protein complex. DNA Repair (Amst). 2002;1:95–107.

    Article  CAS  Google Scholar 

  29. Wang L, Habuchi T, Takahashi T, Mitsumori K, Kamoto T, et al. Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer. Carcinogenesis. 2002;23:257–64.

    Article  PubMed  Google Scholar 

  30. Chung CJ, Huang CJ, Pu YS, Su CT, Huang YK, et al. Polymorphisms in cell cycle regulatory genes, urinary arsenic profile and urothelial carcinoma. Toxicol Appl Pharmacol. 2008;232:203–9.

    Article  CAS  PubMed  Google Scholar 

  31. Lin HH, Ke HL, Hsiao KH, Tsai CW, Wu WJ, et al. Potential role of CCND1 G870A genotype as a predictor for urothelial carcinoma susceptibility and muscle-invasiveness in Taiwan. Chin J Physiol. 2011;54:196–202.

    Article  CAS  PubMed  Google Scholar 

  32. Garcia-Closas M, Malats N, Real FX, Welch R, Kogevinas M, et al. Genetic variation in the nucleotide excision repair pathway and bladder cancer risk. Cancer Epidemiol Biomarkers Prev. 2006;15:536–42.

    Article  CAS  PubMed  Google Scholar 

  33. Liu Y, Wang H, Lin T, Wei Q, Zhi Y, et al. Interactions between cigarette smoking and XPC-PAT genetic polymorphism enhance bladder cancer risk. Oncol Rep. 2012;28:337–45.

    CAS  PubMed  Google Scholar 

  34. da Costa BR, Cevallos M, Altman DG, Rutjes AW, Egger M. Uses and misuses of the strobe statement: bibliographic study. BMJ Open. 2011;1:e000048.

    Article  PubMed Central  PubMed  Google Scholar 

  35. Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet. 1955;19:251–3.

    Article  CAS  PubMed  Google Scholar 

  36. Jackson D, White IR, Riley RD. Quantifying the impact of between-study heterogeneity in multivariate meta-analyses. Stat Med. 2012;31:3805–20.

    Article  PubMed Central  PubMed  Google Scholar 

  37. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Comparison of two methods to detect publication bias in meta-analysis. JAMA. 2006;295:676–80.

    Article  CAS  PubMed  Google Scholar 

  38. Zintzaras E, Ioannidis JP. Heterogeneity testing in meta-analysis of genome searches. Genet Epidemiol. 2005;28:123–37.

    Article  PubMed  Google Scholar 

  39. Cortessis VK, Siegmund K, Xue S, Ross RK, Yu MC. A case–control study of cyclin D1 CCND1 870A → G polymorphism and bladder cancer. Carcinogenesis. 2003;24:1645–50.

    Article  CAS  PubMed  Google Scholar 

  40. Sanyal S, Festa F, Sakano S, Zhang Z, Steineck G, et al. Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis. 2004;25:729–34.

    Article  CAS  PubMed  Google Scholar 

  41. Broberg K, Bjork J, Paulsson K, Hoglund M, Albin M. Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer. Carcinogenesis. 2005;26:1263–71.

    Article  CAS  PubMed  Google Scholar 

  42. Sak SC, Barrett JH, Paul AB, Bishop DT, Kiltie AE. Comprehensive analysis of 22 XPC polymorphisms and bladder cancer risk. Cancer Epidemiol Biomarkers Prev. 2006;15:2537–41.

    Article  CAS  PubMed  Google Scholar 

  43. Wu X, Gu J, Grossman HB, Amos CI, Etzel C, et al. Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes. Am J Hum Genet. 2006;78:464–79.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  44. Zhu Y, Lai M, Yang H, Lin J, Huang M, et al. Genotypes, haplotypes and diplotypes of XPC and risk of bladder cancer. Carcinogenesis. 2007;28:698–703.

    Article  CAS  PubMed  Google Scholar 

  45. Ye Y, Yang H, Grossman HB, Dinney C, Wu X, et al. Genetic variants in cell cycle control pathway confer susceptibility to bladder cancer. Cancer. 2008;112:2467–74.

    Article  CAS  PubMed  Google Scholar 

  46. de Verdier PJ, Sanyal S, Bermejo JL, Steineck G, Hemminki K, et al. Genotypes, haplotypes and diplotypes of three XPC polymorphisms in urinary-bladder cancer patients. Mutat Res. 2010;694:39–44.

    Article  PubMed  Google Scholar 

  47. Gangwar R, Mittal RD. Association of selected variants in genes involved in cell cycle and apoptosis with bladder cancer risk in North Indian population. DNA Cell Biol. 2010;29:349–56.

    Article  CAS  PubMed  Google Scholar 

  48. Yuan L, Gu X, Shao J, Wang M, Zhu Q, et al. Cyclin D1 G870A polymorphism is associated with risk and clinicopathologic characteristics of bladder cancer. DNA Cell Biol. 2010;29:611–7.

    Article  CAS  PubMed  Google Scholar 

  49. Yuan L. Cyclin D1 polymorphism is associated with risk of bladder cancer in China. Nanjing: Nanjing Medical University; 2011.

    Google Scholar 

  50. Liu Y. Interactions of XPC gene polymorphism with prostate cancer and bladder cancer risk in China. Chongqing: Third Military Medical University; 2012.

    Google Scholar 

  51. Cohen LM, McCarthy DM, Brown SA, Myers MG. Negative affect combines with smoking outcome expectancies to predict smoking behavior over time. Psychol Addict Behav. 2002;16:91–7.

    Article  PubMed  Google Scholar 

  52. Shields PG, Harris CC. Cancer risk and low-penetrance susceptibility genes in gene–environment interactions. J Clin Oncol. 2000;18:2309–15.

    CAS  PubMed  Google Scholar 

  53. Goode EL, Ulrich CM, Potter JD. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev. 2002;11:1513–30.

    CAS  PubMed  Google Scholar 

  54. Zeegers MP, Tan FE, Dorant E, van Den Brandt PA. The impact of characteristics of cigarette smoking on urinary tract cancer risk: a meta-analysis of epidemiologic studies. Cancer. 2000;89:630–9.

    Article  CAS  PubMed  Google Scholar 

  55. Hecht SS. Tobacco smoke carcinogens and breast cancer. Environ Mol Mutagen. 2002;39:119–26.

    Article  CAS  PubMed  Google Scholar 

Download references

Conflicts of interest

None

Author information

Authors and Affiliations

  1. Department of Urology, China-Japan Friendship Hospital, No. 2 East Yinghua Road, Beijing, 100029, China

    Yifei Wang, Naibo Liu & Guan Zhang

  2. Out-patient Department, Equipment Academy of Air Force, No.11 An’ningzhuang Road, Haidian District, Beijing, 100085, China

    Zongping Li

Authors
  1. Yifei Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zongping Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Naibo Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Guan Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Zongping Li.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wang, Y., Li, Z., Liu, N. et al. Association between CCND1 and XPC polymorphisms and bladder cancer risk: a meta-analysis based on 15 case–control studies. Tumor Biol. 35, 3155–3165 (2014). https://doi.org/10.1007/s13277-013-1412-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-013-1412-9

Keywords

Search

Navigation